giaconda ltd (GIA:ASX)
giaconda ltd (GIA) Snapshot
|
Open
--
|
Previous Close
--
|
|
|
Day High
--
|
Day Low
--
|
|
|
52 Week High
-- - --
|
52 Week Low
-- - --
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
A$-0.02
|
Shares Outstanding
84.0M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
giaconda ltd (GIA) Related Businessweek News
No Related Businessweek News Foundgiaconda ltd (GIA) Details
Giaconda Limited engages in the development and commercialization of therapies for gastrointestinal diseases and disorders. Its therapies under development include Hepaconda, which is intended for the treatment of hepatitis C virus; and Ibaconda, a combination therapy for the treatment of constipation-predominant irritable bowel syndrome. The company was founded in 2004 and is based in Five Dock, Australia.
giaconda ltd (GIA) Top Compensated Officers
giaconda ltd (GIA) Key Developments
Australian Stock Exchange (the Exchange or ASX) announced that under listing rule 17.6, Giaconda Limited that had not paid its annual listing fees by close of business on August 22, 2012 and is suspended from official quotation before the commencement of trading on August 23, 2012. The Exchange said that the company has not paid its annual listing fee in respect of the year ending June 30, 2013 but is already suspended from official quotation. In accordance with listing rule 16.5, entities that pay their annual listing fees on or after August 23, 2012 must pay by bank cheque only. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm EST on August 29, 2012 will be removed from the official list with effect from the close of trading on August 29, 2012.
| Recently Viewed | |||
| GIA:AU | A$0.00 AUD | 0.00 |  |
| Company | Last | Change | |
| No competitor information is available for GIA. | |||
| View Industry Companies | |||
Industry Analysis
GIA
Industry Average
| Valuation | GIA | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 637.4x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 479.1x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact GIACONDA LTD, please visit www.giacondalimited.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
